title: Disease-associated prion protein is not detectable in human systemic amyloid deposits.
abstract: Cerebral and cardiac amyloid deposits have been reported after scrapie infection in transgenic mice expressing variant prion protein (PrP(C)) lacking the glycophosphatidylinositol anchor. The amyloid fibril protein in the systemic amyloid deposits was not characterized, and there is no clinical or pathological association between prion diseases and systemic amyloidosis in humans. Nevertheless, in view of the potential clinical significance of these murine observations, we tested both human amyloidotic tissues and isolated amyloid fibrils for the presence of PrP(Sc), the prion protein conformation associated with transmissible spongiform encephalopathy (TSE). We also sequenced the complete prion protein gene, PRNP, in amyloidosis patients. No specific immunohistochemical staining for PrP(Sc) was obtained in the amyloidotic cardiac and other visceral tissues of patients with different types of systemic amyloidosis. No protease-resistant prion protein, PrP(res), was detectable by Western blotting of amyloid fibrils isolated from cardiac and other systemic amyloid deposits. Only the complete normal wild-type PRNP gene sequence was identified, including the usual distribution of codon 129 polymorphisms. These reassuringly negative results do not support the idea that there is any relationship of prions or TSE with human systemic amyloidosis, including cardiac amyloid deposition.
authors.affiliation: Centre for Amyloidosis and Acute Phase Proteins (incorporating the UK NHS National Amyloidosis Centre), Department of Medicine, University College London, London NW3 2PF, UK. g.tennent@medsch.ucl.ac.uk
authors.forename: G A
authors.initials: GA
authors.lastname: Tennent
authors.forename: M W
authors.initials: MW
authors.lastname: Head
authors.forename: M
authors.initials: M
authors.lastname: Bishop
authors.forename: P N
authors.initials: PN
authors.lastname: Hawkins
authors.forename: R G
authors.initials: RG
authors.lastname: Will
authors.forename: R
authors.initials: R
authors.lastname: Knight
authors.forename: A H
authors.initials: AH
authors.lastname: Peden
authors.forename: L M
authors.initials: LM
authors.lastname: McCardle
authors.forename: J W
authors.initials: JW
authors.lastname: Ironside
authors.forename: M B
authors.initials: MB
authors.lastname: Pepys
mesh_terms: D000293:Adolescent; D000368:Aged; D000682:Amyloid / Q000737:chemistry; D000686:Amyloidosis / Q000209:etiology* / Q000378:metabolism*; D009202:Cardiomyopathies / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction / Q000379:methods; D018620:PrPSc Proteins / Q000032:analysis*; D017096:Prion Diseases / Q000150:complications*; D000072002:Prion Proteins; D011328:Prions / Q000235:genetics; D017422:Sequence Analysis, DNA / Q000379:methods
chemical_list: D000682:Amyloid; C512656:PRNP protein, human; D018620:PrPSc Proteins; D000072002:Prion Proteins; D011328:Prions